Comparative efficacy of tocotrienol and tocopherol (vitamin E) on atherosclerotic cardiovascular diseases in humans
Journal of the Pakistan Medical Association · 2024
DOI: 10.47391/jpma.9227 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of the Pakistan Medical Association, 2024. Verfasst von Saima Rafique und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, Wah Medical College, Wah Cantt, National University of Medical Sciences, Rawalpindi, Pakistan. Hauptthemen laut MEDLINE: Tocotrienols, Atherosclerosis, Tocopherols, Antioxidants. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To compare the efficacy of tocotrienol and tocopherol in the management of patients with atherosclerotic cardiovascular diseases.
Method
The systematic review was conducted in line with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines 2020, and comprised literature search from 2002 till January 5, 2023, on PubMed, Google Scholar, Cochrane Library, Google, Wiley-Inter Science Library, Medline, SpringerLink and Taylor and Francis databases. The search was conducted using key words, such as: “tocopherol”, “tocotrienol”, “vitamin E”, “dyslipidaemia”, “cardiovascular diseases” “cardioprotective”, “hypercholesterolemia” and “atherosclerosis” along with Boolean operators. Human clinical studies regarding the use of tocotrienol or tocopherol or comparison of its efficacy in patients having atherosclerosis, dyslipidaemia leading to cardiovascular diseases, and studies including details of efficacy of any of the four alpha, beta, gamma, delta isomers of tocopherol or tocotrienol were included. Pertinent data from the eligible studies was retrieved and reviewed.
Results
Of the 516 articles identified, 12(2.3%) were subjected to detailed analysis. Tocotrienol showed better anti-oxidant efficacy by decreasing inflammatory biomarkers, normalising serum lipid parameters and modulating micro-ribonucleic acid involved in cardiovascular diseases. Tocopherol shown heterogeneity of results by either decreasing or increasing the risk of mortality in atherosclerotic cardiovascular diseases.
Conclusion
Compared to tocopherol, tocotrienol was found to be safe and potential candidate for improving cardiovascular health in the management of atherosclerotic cardiovascular diseases. Key Words: Cardiovascular diseases, Vitamin E, Atherosclerosis, Tocotrienol, Dyslipidaemia, Tocopherol, Hypercholesterolemia, Human studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Therapeutics, Wah Medical College, Wah Cantt, National University of Medical Sciences, Rawalpindi, Pakistan.
- Department of Pathology, National University of Medical Sciences, Rawalpindi, Pakistan.
- Department of Pharmacology and Therapeutics, Army Medical College, National University of Medical Sciences, Rawalpindi, Pakistan.
- National University of Medical Sciences, Rawalpindi, Pakistan.
Zitieren
APA
Rafique, S., Khan, D. A., Farhat, K., Khan, M. A., Noor, M., & Sharif, M. (2024). Comparative efficacy of tocotrienol and tocopherol (vitamin E) on atherosclerotic cardiovascular diseases in humans. Journal of the Pakistan Medical Association. https://doi.org/10.47391/jpma.9227
Vancouver
Rafique S, Khan DA, Farhat K, Khan MA, Noor M, Sharif M. Comparative efficacy of tocotrienol and tocopherol (vitamin E) on atherosclerotic cardiovascular diseases in humans. Journal of the Pakistan Medical Association. 2024. doi:10.47391/jpma.9227
BibTeX
@article{Rafique2024,
author = {Rafique, Saima and Khan, Dilshad Ahmed and Farhat, Kulsoom and Khan, Muhammad Asghar and Noor, Mudassar and Sharif, Mahjabeen},
title = {Comparative efficacy of tocotrienol and tocopherol (vitamin E) on atherosclerotic cardiovascular diseases in humans},
journal = {Journal of the Pakistan Medical Association},
year = {2024},
doi = {10.47391/jpma.9227}
}
EUVIMED